Did you know? CSL is investigating a potential treatment to improve the health of people living with end-stage kidney disease (ESKD). 

Vaccination is one of the most effective and cost-effective public health interventions which has helped reduce the burden of many infectious diseases. Professor Helen Marshall AM is an international leader in vaccine research and translating this into practice and policy and she shared her vaccinology journey for the Feery Oration at #CDIC2025 . #CSLSeqirus proudly sponsors the oration in honour of Dr Brian Feery, another distinguished scientist and major contributor to public health in Australia through research in influenza, smallpox, Q Fever, and paediatric vaccines. Learn more: https://bit.ly/4jNCqlQ #Immunisation #WHO #PublicHealth

Superior performance starts with a mindset. At CSL, we turn imagination into action, action into results, and challenges into breakthroughs. When we ask, “How can this be better?” we follow through. When we reach beyond expectations, we celebrate. Join a team that’s committed to excellence in every step. #PromisingFutures #CSL Explore careers at CSL: https://bit.ly/44luCCv

By working closely with health care professionals, patient advocacy groups and research institutions, we ensure that our innovations reach the people who need them most. Our mission is clear: to provide life-saving and life-enhancing therapies to patients worldwide. Learn more about our global impact: https://bit.ly/3FNxG1R

It is exciting to see CSL Seqirus brand new, world-class vaccine and antivenom manufacturing facility in Melbourne coming to life. Members of the Australian Technical Advisory Group on Immunisation \(ATAGI\) recently toured the site to gain a better understanding of the facility's scale, the anticipated seasonal operations, and how CSL Seqirus would respond in the event of an influenza pandemic. Joining them were representatives from the Department of Health, Disability and Ageing, who organized the tour as part of ATAGI’s industry engagement activities. Learn more about CSL Seqirus here: https://bit.ly/4kUJ9vt #CSL #CSLSeqirus #CSLManufacturing #Manufacturing #Melbourne #ATAGI

CSL Vifor is pleased to support Kidney Disease: Improving Global Outcomes \(KDIGO\) in advancing guideline implementation efforts with the next generation of nephrologists aiming at improving patient outcomes and reducing the growing burden of kidney disease. The first milestone in this medical education program will take place at ERA 2025 in Vienna, where KDIGO will welcome participants to the inaugural meeting of the KDIGO Early Career Professionals \(ECP\) Guideline Implementation Program, a unique activity that will bring together professionals in the field of nephrology to advance patient care by guideline implementation efforts. We look forward to supporting KDIGO and contributing to a meaningful, long-term impact in nephrology education and evidence-based medicine. #Nephrology #KDIGO #MedicalEducation #ERA25 #HealthcareInnovation #CSLVifor

Happy Pride Month! 🌈 Today and every day, we celebrate love, identity, and the power of living authentically. Here's to a world where everyone can shine as their true selves. https://bit.ly/43rcIPr #CSL #Pride #LoveIsLove

Apply now for CSL's Award Winning Australian 2025 Intern Program! Join our collaborative, dynamic environment that fosters innovation. https://bit.ly/4dHHnLL #PromisingFutures #Internship #CSL #DoWorkThatMatters

We thank Lily, a gold-medal-winning Special Olympics Pennsylvania athlete, for bringing so much sunshine to our King of Prussia, PA, campus on a rainy afternoon. An overflow crowd of employees turned out for CSL’s Special Olympics fundraiser, and "Lily from Philly", who also works at Lincoln Financial Field on game days, shared the story of her swimming victory at the USA Games. Learn more about the Special Olympics Pennsylvania , how the organization is making a difference for people with intellectual disabilities, and how you can help: https://bit.ly/4kJhrBO #SpecialOlympics #CSL #SpecialOlympicsPA

1 in 50,000 people live with hereditary angioedema \(#HAE \) – a rare and debilitating genetic disease that causes painful and potentially life-threatening swelling attacks. Arianna is just one of those affected by HAE, and it’s for people like her that we strive to ‘never give up’ to tirelessly advance new solutions for HAE treatments and provide hope to all those affected by HAE. Read more of Arianna’s experience with HAE and her hopes for the future of HAE treatment: https://lnkd.in/eT9XUEjU #CSL